Oncology
1 drug is in development for Advanced Breast Cancer.
- Companies
- 1
- Clinical trials
- 30
BioSniper AIPage evidence connected
Prepared research question
Which programs lead the Advanced Breast Cancer pipeline—and what evidence could change the picture?
Run cited research
Traceable citations · Unknowns marked
Drug Pipeline by Phase
Phase 2(1)
| Drug | Company |
|---|---|
| lerociclib | EQRx, Inc. (EQRX) |
About this indication
Advanced Breast Cancer context
Oncology·MeSH: Breast Neoplasms (D001943)
Narrower concept of MeSH descriptor Breast Neoplasms
Prevalence
287.0 / 100K
Incidence
128.0 / 100K/yr
Frequently asked questions
How many drugs are in development for Advanced Breast Cancer?
BioSniper tracks 1 drug in development for Advanced Breast Cancer across 1 company.
How many clinical trials target Advanced Breast Cancer?
There are 30 clinical trials targeting Advanced Breast Cancer tracked by BioSniper.
What is the prevalence of Advanced Breast Cancer?
The estimated prevalence of Advanced Breast Cancer is approximately 287.0 per 100,000 population.